NCT05630794 2026-03-19
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
National Cancer Institute (NCI)
Rapamycin Holdings Inc.
HonorHealth Research Institute
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)